 |
|
Spontaneous Factor XI InhibitorsSeven Additional Cases and a Review of the Literature
E. Albert Reece, MD;
Lionel P. Clyne, FIMLS, MS;
Roberto Romero, MD;
John C. Hobbins, MD
Arch Intern Med. 1984;144(3):525-529.
Abstract
• Circulating anticoagulants are endogenous blood components that inhibit the action of clotting factors. In some inhibitor conditions this inactivation in the function of the hemostatic system may lead to life-threatening hemorrhagic diathesis. Inhibitors directed against factor XI are generally associated with little or no impairment of the hemostatic system. We analyzed all reported cases of spontaneous factor XI inhibitor in the international literature, as well as cases identified at the Yale—New Haven (Conn) Hospital between 1970 and 1980, considering clinical spectrum, diagnosis, and therapy.
(Arch Intern Med 1984;144:525-529)
Author Affiliations
From the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Yale University School of Medicine (Drs Reece, Romero, and Hobbins), and the Department of Clinical Laboratories, Yale—New Haven Medical Center, New Haven, Conn (Mr Clyne).
Footnotes
Accepted for publication Aug 22, 1983.
Reprint requests to Department of Obstetrics and Gynecology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510 (Dr Reece).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
|
